Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives;Mesenchymale stammzellen des knochenmarks. Phänotyp, aspekte der biologie und klinische perspektiven

Medizinische Klinik

Volumn 101, Issue 5, 2006, Pages 408-413

  Wulf, Gerald G ^a   Chapuy, Björn ^b   Trümper, Lorenz ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

Bone marrow; Cellular therapy; Mesenchymal stem cell

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYME CELL; MESODERM; PHENOTYPE; REVIEW;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FORECASTING; GERMANY; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RESEARCH;

ANIMALIA;

EID: 33646577453     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1052-6     Document Type: Review

References (70)

1. Agematsu K, Nakahori Y. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone-marrow transplantation in humans. Br J Haematol 1991;79:359-65.
2. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22.
3. Barry FP, Murphy JM, English K, et al. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Devel 2005;14:252-65.
4. Bianchi DW. Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 2000;92:103-8.
5. Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells (Dayt) 2004;22:625-34.
6. Bonyadi M, Waldman SD, Liu DM, et al. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci U S A 2003;100: 5840-5.
7. Borue X, Lee S, Grove J, et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 2004;165:1767-72.
8. Buckner CD, Epstein RB, Rudolph RH, et al. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. Blood 1970;35:741-50.
9. Campagnoli C, Roberts IAG, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-402.
10. Caplan AI. The mesengenic process. Clin Plast Surg 1994;21:429-35.
11. Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000;97:3213-8.
12. De Kok IJ, Peter SJ, Archambault M, et al. Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: preliminary findings. Clin Oral Implants Res 2003;14:481-9.
13. Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001;29:244-55.
14. DiGirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999;107: 275-281.
15. Eliopoulos N, Al Khaldi A, Crosato M, et al. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in non-myeloablated, immunocompetent mice. Gene Ther 2003;10:478-89.
16. Forbes SJ, Russo FP, Rey V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human, liver fibrosis. Gastroenterology 2004; 126:955-63.
17. Friedenstein AJ, Deriglas UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by in vitro colony assay method. Exp Hematol 1974;2:83-92.
18. Friedenstein AJ, Gorskaja UF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-74.
19. Gao JZ, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stent cells after infusion. Cells Tissues Organs 2001;169:12-20.
20. Gazit D, Turgeman G, Kelley P, et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999;1:121-33.
21. Gronthos S, Graves SE, Ohta S, et al. The Stro-1 (+) fraction of adult human bone-marrow contains the osteogenic precursors. Blood 1994;84:4164-73.
22. Haynesworth SE, Baber MA, Caplan AI. Cell-surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
23. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002;99:2199-204.
24. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002;99: 8932-7.
25. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5.
26. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-13.
27. Horwitz EM, Prockop DJ, Gordon PL, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001;97:1227-31.
28. Huss R. Isolation of primary and immortalized CD34(-) hematopoietic and mesenchymal stem cells from various sources. Stem Cells 2000;18:1-9.
29. Johnson KL, Nelson JL, Furst DE, et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 2001;44: 1848-54.
30. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-98.
31. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005;79:1607-14.
32. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
33. Li Y, Chen JL, Wang L, et al. Intracerebral transplantation of bone marrow-derived mesenchymal cells after stroke in adult mice. Stroke 2000;31:277.
34. Mankani MH, Kuznetsov SA, Fowler B, et al. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 2001;72:96-107.
35. Maximov A. Der Lymphozyt als gemeinsame Stammzelle der verschiedenen Blutelemente in der embryonalen Entwicklung und im postfetalen Leben der Säugetiere. Folia Haematol 1907;4:611-26
36. Mcglave P, Verfaillie C, Miller J. Interaction of primitive human myeloid and lymphoid progenitors with the marrow microenvironment. Blood Cells 1994;20:121-8.
37. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21.
38. Mizuno H, Zuk PA, Zhu M, et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002;109:199-209.
39. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90.
40. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 1997;88:287-98.
41. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem-cells is deterministic and isolatable by phenotype. Immunity 1994; 1:661-73.
42. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62.
43. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003;100:8407-11.
44. Pereira RF, Halford KW, Ohara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Nad Acad Sci U S A 1995;92:4857-61.
45. Pereira RF, O'Hara MD, Laptev AV, et al. Marrow stromal cells as a source of progenitor cells for non-hematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 1998;95:1142-7.
46. Pittenger MF, Mackay AM, Beck SC, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
47. Prockop DJ. Marrow stromal cells as steam cells for nonhematopoietic tissues. Science 1997;276:71-4.
48. Roelen DL, in't Anker ES, van Beelen E, et al. The use of mesenchymal stem cells as a tool for immunomodulation of the alloimmune response in pregnancy and solid organ transplantation. Genes Immun 2004;5:S2.
49. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003;21:105-10.
50. Saito T, Kuang JG, Lin CCH, et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 2003;126:114-23.
51. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-63.
52. Schwartz RE, Jiang YH, Blackstad M, et al. Multi-potent adult progenitor cells from bone marrow differentiate into urea producing hepatocyte-like cells. Blood 2001;98:791A.
53. Schwarz EJ, Alexander GM, Prockop DJ, et al. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther 1999;10:2539-49.
54. Seo MJ, Suh SY, Bae YC, et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005;328:258-64.
55. Simmons PJ, Przepiorka D, Thomas ED, et al. Host origin of marrow stromal cells following allogeneic bone-marrow transplantation. Nature 1987;328:429-32.
56. Simmons PJ, Torokstorb B. Identification of stromal cell precursors in human bone-marrow by a novel monoclonal antibody, Stro-1. Blood 1991;78:55-62.
57. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem-cells. Science 1988;241:58-62.
58. Srivatsa B, Srivatsa S, Johnson KL, et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001;358:2034-8.
59. Studeny M, Marini FC, Champlin RE, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603-8.
60. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
61. Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005;23:1105-12.
62. Tsuchida H, Hashimoto J, Crawford E, et al. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res 2003;21:44-53.
63. Turgeman G, Pittman DD, Muller R, et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 2001;3:240-51.
64. Turgeman G, Zilberman Y, Zhou SH, et al. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 2002;86:461-74.
65. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33:1402-16.
66. Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal "stem" cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003;121:368-74.
67. Wu GD, Nolta JA, Jin YS, et al. Migration, of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003;75:679-85.
68. Wulf GG, Viereck V, Hemmerlein B, et al. Mesengenic progenitor cells derived from human placenta. Tissue Eng 2004;10:1136-47.
69. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12.
70. Zhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002;174:11-20.